SUE ROSE: Open Payments
NPI 1902064983 · RIVERDALE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$654 in 33 payments from 12 companies in 2025. Trend: 2023 $218 · 2024 $309 · 2025 $654
Food & beverage: $654
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $151 |
| Novo Nordisk Inc | 7 | $122 |
| Exact Sciences Corporation | 3 | $81 |
| PFIZER INC. | 3 | $68 |
| Lilly USA, LLC | 3 | $58 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Bard Peripheral Vascular, Inc. | 1 | $36 |
| Seqirus USA Inc | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| ABBVIE INC. | 1 | $17 |
Products named: Cologuard Collection Kit, BREZTRI, FARXIGA, PREVNAR 20, Wegovy, SHINGRIX, MOUNJARO, Ozempic.
Industry payments across NJ — which companies pay providers there.
